Simplex Trading
NVCT icon

Simplex Trading’s Nuvectis Pharma NVCT Stock Holding History

Simplex Trading’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$315K Sell
14,932
-16,462
-52% -$347K ﹤0.01% 4108
2026
Q2 		$577K Buy
31,394
+28,798
+1,109% +$322K ﹤0.01% 3427
2026
Q1 		$20.1K Buy
+2,596
New +$22.2K ﹤0.01% 6785
2025
Q3 		– Sell
-2,114
Closed -$14.5K – 9740
2025
Q2 		$15K Buy
+2,114
New +$19.2K ﹤0.01% 7018

Other funds holding NVCT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Iridian Asset Management
Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Baldwin Wealth Partners
Baldwin Wealth Partners Marion, Massachusetts $1.52B AUM 21.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Simplex Trading's NVCT Position: Q3 2026 in Review

Simplex Trading reduced its Nuvectis Pharma (NVCT) stake by 52% in Q3 2026, selling an estimated $347K and leaving 14,932 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #4108.

Simplex Trading first reported a position in NVCT in Q2 2025 and has held it in 4 quarters since. The position peaked at $577K in Q2 2026. 58 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.

  • Simplex Trading held 14,932 shares of Nuvectis Pharma worth $315K as of Q3 2026.
  • Simplex Trading sold 16,462 Nuvectis Pharma shares in Q3 2026, an estimated $347K.
  • Nuvectis Pharma made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #4108 holding.
  • Simplex Trading first reported a position in Nuvectis Pharma in Q2 2025 and has held it in 4 quarters since.
  • Simplex Trading's Nuvectis Pharma position peaked at $577K in Q2 2026.
  • 58 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.